- Contractors
- Ad Astra Diagnostics, Inc.
Ad Astra Diagnostics, Inc.
Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)
Ad Astra Diagnostics has 1 federal contract of $100,000 or more active since October 2023, with $6.7M obligated, from 1 agency. 1 is still running.
- Contracts
- 1 since FY2024$6,702,732 obligated, contracts of $100,000 or more
- Running now
- 1 contract
- Biggest customer
- Office of Assistant Secretary for Preparedness and Response$6.7M on 1 contract
- Main industry
- Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714
- UEI
- LED6PKVTAH33Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Running contracts
Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.
| Contract | Obligated | Ends | State |
|---|---|---|---|
| Ad Astra Diagnostics, Inc. (Plus) &D for Clia-Waived Ubiquitous Early Sepsis Detection, Severity in Ambulance, Pre-Hospital, Post- Discharge Aoi #02+: Infection Severity and Solving SepsisOffice of Assistant Secretary for Preparedness and Response · 75A50124C00053 | $6,702,732 | Dec 17, 2028in 25 months | NC |
End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| Office of Assistant Secretary for Preparedness and Response1 contract | $6,702,732 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 1 contract | $6,702,732 |
Where the work is
| Place of work | Amount | Share |
|---|---|---|
| North Carolina1 contract | $6,702,732 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Office of Assistant Secretary for Preparedness and Response: see the list.
Get new notices like Ad Astra Diagnostics's work
New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy